Page last updated: 2024-10-22

albuterol and Brain Disorders

albuterol has been researched along with Brain Disorders in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, J1
Cui, Z1
Liu, S1
Gao, X1
Gao, P1
Shi, Y1
Guo, S1
Li, P1

Other Studies

1 other study available for albuterol and Brain Disorders

ArticleYear
Early use of noninvasive techniques for clearing respiratory secretions during noninvasive positive-pressure ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease and hypercapnic encephalopathy: A prospective cohort stud
    Medicine, 2017, Volume: 96, Issue:12

    Topics: Aged; Albuterol; Ambroxol; Brain Diseases; Equipment Design; Feasibility Studies; Female; Humans; Hy

2017